Open AccessClinical features, prognostic factors, and antibody effects in anti-mGluR1 encephalitis
Author(s) -
Marianna Spatola,
Mar PetitPedrol,
Estibaliz Maudes,
Mateus Mistieri Simabukuro,
Sergio MuñizCastrillo,
Anne Laurie Pinto,
Klaus Peter Wandinger,
Juliane Spiegler,
Peter Schramm,
Lívia Almeida Dutra,
Raffaele Iorio,
Cornelia Kornblum,
Christian G. Bien,
Romana Höftberger,
Frank Leypoldt,
Maarten J. Titulaer,
Peter Sillevis Smitt,
Jérôme Honnorat,
Myrna R. Rosenfeld,
Francesc Graus,
Josep Dalmau
Publication year - 2020
Publication title -
neurology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.91
H-Index - 364
eISSN - 1526-632X
pISSN - 0028-3878
DOI - 10.1212/wnl.0000000000010854
Subject(s) - metabotropic glutamate receptor 1 , medicine , metabotropic glutamate receptor , modified rankin scale , encephalitis , pathology , immunology , glutamate receptor , receptor , virus , ischemic stroke , ischemia
To clinically characterize patients with anti-metabotropic glutamate receptor (mGluR) 1 encephalitis, to identify prognostic factors, and to study the immunoglobulin G (IgG) subclasses and effects of antibodies on neuronal mGluR1 clusters.